proline has been researched along with maraviroc in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 2 (66.67) | 24.3611 |
2020's | 1 (33.33) | 2.80 |
Authors | Studies |
---|---|
Binet, L; Djerada, Z; Feliu, C; Gozalo, C; Lamiable, D; Marty, H; Millart, H; Robinet, A; Tournois, C; Vautier, D | 1 |
Fang, A; Heera, J; Kantaridis, C; Plotka, A; Vourvahis, M | 1 |
AlAjmi, MF; Anwar, S; Hassan, MI; Hussain, A; Islam, A; Mohammad, T; Rehman, MT; Shamsi, A | 1 |
1 trial(s) available for proline and maraviroc
Article | Year |
---|---|
The effects of boceprevir and telaprevir on the pharmacokinetics of maraviroc: an open-label, fixed-sequence study in healthy volunteers.
Topics: Adolescent; Adult; Antiviral Agents; Cyclohexanes; Healthy Volunteers; Humans; Male; Maraviroc; Middle Aged; Oligopeptides; Proline; Triazoles; Young Adult | 2014 |
2 other study(ies) available for proline and maraviroc
Article | Year |
---|---|
Validation of a fast method for quantitative analysis of elvitegravir, raltegravir, maraviroc, etravirine, tenofovir, boceprevir and 10 other antiretroviral agents in human plasma samples with a new UPLC-MS/MS technology.
Topics: Adenine; Anti-Retroviral Agents; Chromatography, High Pressure Liquid; Cyclohexanes; Humans; Maraviroc; Mass Spectrometry; Nitriles; Organophosphonates; Proline; Pyridazines; Pyrimidines; Pyrrolidinones; Quinolones; Raltegravir Potassium; Tandem Mass Spectrometry; Tenofovir; Time Factors; Triazoles | 2013 |
Glecaprevir and Maraviroc are high-affinity inhibitors of SARS-CoV-2 main protease: possible implication in COVID-19 therapy.
Topics: Aminoisobutyric Acids; Antiviral Agents; Betacoronavirus; Computer Simulation; Cyclopropanes; Drug Evaluation, Preclinical; Lactams, Macrocyclic; Leucine; Maraviroc; Molecular Structure; Proline; Protease Inhibitors; Quinoxalines; SARS-CoV-2; Sulfonamides | 2020 |